The Webinar will be focused on the rationale, benefits and risks of using early hydrocortisone in extremely preterm infants to improve survival without BPD. Different aspects will be shown including current evidence through RCTs, real-world data and potential options to improve the benefit/risk balance of this prophylactic treatment.